Cytokinetics Inc (CYTK) - Financial and Strategic SWOT Analysis Review

  • ID: 4267292
  • SWOT Analysis
  • 46 pages
  • GlobalData
1 of 5

FEATURED COMPANIES

  • Eisai Co Ltd
  • Ionis Pharmaceuticals Inc
  • MediciNova Inc
  • Orphazyme A/S
  • MORE
Cytokinetics Inc (CYTK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:
  • Business description - A detailed description of the company’s operations and business divisions.
  • Corporate strategy - Analyst’s summarization of the company’s business strategy.
  • SWOT Analysis - A detailed analysis of the company’s strengths, weakness, opportunities and threats.
  • Company history - Progression of key events associated with the company.
  • Major products and services - A list of major products, services and brands of the company.
  • Key competitors - A list of key competitors to the company.
  • Key employees - A list of the key executives of the company.
  • Executive biographies - A brief summary of the executives’ employment history.
  • Key operational heads - A list of personnel heading key departments/functions.
  • Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
  • Key manufacturing facilities - A list of key manufacturing facilities of the company.
  • Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
  • Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights

Cytokinetics Inc (Cytokinetics) is a late stage biopharmaceutical company, which discovers, develops, and commercializes muscle activators for the treatment of diseases associated with reduced muscle performance. The company’s pipeline encompasses omecamtiv mecarbil, a novel cardiac myosin activator in Phase 3 for heart failure; and reldesemtiv, a next-generation fast skeletal muscle troponin activator in Phase 2 for the treatment of spinal muscular atrophy; chronic obstructive pulmonary disease; and in Phase 1b for frailty. It is also investigating reldesemtiv for amyotrophic lateral sclerosis. It has licensing agreements with Amgen and Astellas for advancing its drug candidates. Cytokinetics is headquartered in South San Francisco, California, the US.

Cytokinetics Inc Key Recent Developments

Feb 15, 2018: Cytokinetics Reports Fourth Quarter 2017 Financial Results
Feb 12, 2018: Cytokinetics Appoints Robert Califf, M.D., to Board of Directors
Nov 30, 2017: New Publication Shows Respiratory Decline Correlated With Disease Progression in People Living With ALS
Oct 26, 2017: Cytokinetics Reports Third Quarter 2017 Financial Results
Aug 02, 2017: Cytokinetics Reports Second Quarter 2017 Financial Results

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
  • The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
  • The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
  • Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
  • Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
  • Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
READ MORE
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Eisai Co Ltd
  • Ionis Pharmaceuticals Inc
  • MediciNova Inc
  • Orphazyme A/S
  • MORE
Section 1 - About the Company
  • Cytokinetics Inc - Key Facts
  • Cytokinetics Inc - Key Employees
  • Cytokinetics Inc - Key Employee Biographies
  • Cytokinetics Inc - Major Products and Services
  • Cytokinetics Inc - History
  • Cytokinetics Inc - Company Statement
  • Cytokinetics Inc - Locations And Subsidiaries
  • Head Office
Section 2 - Company Analysis
  • Company Overview
  • Cytokinetics Inc - Business Description
  • R&D Overview
  • Cytokinetics Inc - SWOT Analysis
  • SWOT Analysis - Overview
  • Cytokinetics Inc - Strengths
  • Cytokinetics Inc - Weaknesses
  • Cytokinetics Inc - Opportunities
  • Cytokinetics Inc - Threats
  • Cytokinetics Inc - Key Competitors
Section 3 - Company Financial Ratios
  • Financial Ratios - Capital Market Ratios
  • Financial Ratios - Annual Ratios
  • Performance Chart
  • Financial Performance
  • Financial Ratios - Interim Ratios
  • Financial Ratios - Ratio Charts
Section 4 - Company’s Lifesciences Financial Deals and Alliances
  • Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Cytokinetics Inc, Recent Deals Summary
Section 5 - Company’s Recent Developments
  • Feb 15, 2018: Cytokinetics Reports Fourth Quarter 2017 Financial Results
  • Nov 30, 2017: New Publication Shows Respiratory Decline Correlated With Disease Progression in People Living With ALS
  • Oct 26, 2017: Cytokinetics Reports Third Quarter 2017 Financial Results
  • Aug 02, 2017: Cytokinetics Reports Second Quarter 2017 Financial Results
  • Apr 27, 2017: Cytokinetics Reports First Quarter 2017 Financial Results
  • Feb 16, 2017: Cytokinetics Reports Fourth Quarter 2016 Financial Results
Section 6 - Appendix
  • Methodology
  • Ratio Definitions
  • About
  • Contact
  • Disclaimer
List of Tables
  • Cytokinetics Inc, Key Facts
  • Cytokinetics Inc, Key Employees
  • Cytokinetics Inc, Key Employee Biographies
  • Cytokinetics Inc, Major Products and Services
  • Cytokinetics Inc, History
  • Cytokinetics Inc, Key Competitors
  • Cytokinetics Inc, Ratios based on current share price
  • Cytokinetics Inc, Annual Ratios
  • Cytokinetics Inc, Annual Ratios
  • Cytokinetics Inc, Annual Ratios
  • Cytokinetics Inc, Interim Ratios
  • Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018
  • Cytokinetics Inc, Recent Deals Summary
  • Currency Codes
  • Capital Market Ratios
  • Equity Ratios
  • Profitability Ratios
  • Cost Ratios
  • Liquidity Ratios
  • Leverage Ratios
  • Efficiency Ratios
List of Figures
  • Cytokinetics Inc, Performance Chart (2013 - 2017)
  • Cytokinetics Inc, Ratio Charts
  • Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Cytokinetics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5
  • Orphazyme A/S
  • Neuraltus Pharmaceuticals Inc
  • Mitsubishi Tanabe Pharma Corp
  • MediciNova Inc
  • Ionis Pharmaceuticals Inc
  • Genervon Biopharmaceuticals LLC
  • Eisai Co Ltd
Note: Product cover images may vary from those shown
5 of 5
Note: Product cover images may vary from those shown
Adroll
adroll